1993
DOI: 10.1016/0167-4838(93)90291-x
|View full text |Cite
|
Sign up to set email alerts
|

Activity modulation of the fast and slow isozymes of human cytosolic low-molecular-weight acid phosphatase (ACP1) by purines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
24
0

Year Published

1994
1994
2013
2013

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(25 citation statements)
references
References 55 publications
1
24
0
Order By: Relevance
“…Furthermore, it has been demonstrated (Stefani et al, 1993) that the 5-16 phosphotyrosines present in the N-terminal peptide of human B3P are more efficiently dephosphorylated by f isoforms than by s isoforms [K m (mM) 1.4→0.4; V max (µmol·min -1 ·mg -1 ) 68→10.5]. In light of that mentioned above, our data show that f isoforms, which are more sensitive to oxidative damage compared to s isoforms (Luffman and Harris, 1967;Fisher and Harris, 1971;Bottini et al, 1971b), are likely to undergo inhibition by Vfe more than that reported in the last column of Table 1, where the f activity is calculated reducing it by the same proportion of s as reported by Dissing et al (1993) and where the much higher inhibition of f isoforms compared to s isoforms is not taken into consideration. Therefore, considering that the values of f isoform activities in the presence of Vfe will be certainly lower than those that we have calculated here (i.e., AA = 6.42; CA = 3.64; CC = 5.00), the real f activity associated with ACP 1 AA, ACP 1 CA, ACP 1 CC genotypes will reach extremely low values.…”
Section: Discussionsupporting
confidence: 60%
See 1 more Smart Citation
“…Furthermore, it has been demonstrated (Stefani et al, 1993) that the 5-16 phosphotyrosines present in the N-terminal peptide of human B3P are more efficiently dephosphorylated by f isoforms than by s isoforms [K m (mM) 1.4→0.4; V max (µmol·min -1 ·mg -1 ) 68→10.5]. In light of that mentioned above, our data show that f isoforms, which are more sensitive to oxidative damage compared to s isoforms (Luffman and Harris, 1967;Fisher and Harris, 1971;Bottini et al, 1971b), are likely to undergo inhibition by Vfe more than that reported in the last column of Table 1, where the f activity is calculated reducing it by the same proportion of s as reported by Dissing et al (1993) and where the much higher inhibition of f isoforms compared to s isoforms is not taken into consideration. Therefore, considering that the values of f isoform activities in the presence of Vfe will be certainly lower than those that we have calculated here (i.e., AA = 6.42; CA = 3.64; CC = 5.00), the real f activity associated with ACP 1 AA, ACP 1 CA, ACP 1 CC genotypes will reach extremely low values.…”
Section: Discussionsupporting
confidence: 60%
“…We also reported the f isoforms' mean activity of ACP 1 phenotypes calculated according to Dissing et al (1993 Values assuming that the activity of both f and s isoforms is reduced by the same percentage.…”
Section: Resultsmentioning
confidence: 99%
“…Activation studies of the wild-type isoenzymes and the HPTP-B mutants by cGMP were performed using the procedure outlined by Dissing et al (19). The activity at saturation, V m Ј, is presented as an increased percentage in activity relative to what is seen without cGMP.…”
Section: Resultsmentioning
confidence: 99%
“…Both isoenzyme forms have been isolated from rat, chicken, Xenopus laevis, and Drosophila (8 -13), whereas the single Tritrichomonas fetus enzyme is similar to HPTP-A (14) and the Mycobacterium tuberculosis, yeast, and bovine enzymes are similar to HPTP-B (15)(16)(17)(18). The human isoenzymes exhibit a dramatically different response to a variety of purine molecules (19,20). In particular, adenine has been shown to inhibit HPTP-A and activate HPTP-B, whereas hypoxanthine activates HPTP-A with little to no effect on HPTP-B.…”
mentioning
confidence: 99%
“…The physiological role of the yeast enzymes is still unknown but the mammalian LMW-PTP shows a broad range of substrates including the PDGF and insulin receptors [11], caveolin [12], and the p190Rho GAP [13]. The activation of mammalian LMW-PTP by purines or purine derivatives, nucleosides, and nucleotides has been described [14][15][16], together with the activity modulation of human LMW-PTP by adenine and hypoxanthine [17]. The mechanism of the activation of the LMW-PTP by purines is not completely understood.…”
mentioning
confidence: 99%